U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  1. Compliance Actions and Activities

Learn about the types of warning letters on FDA's website.

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
  • To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.
 


Posted Date Letter Issue Date Company Name Issuing Office Subject Response Letter Closeout Letter Excerpt
Vapors Inc. d/b/a Vapors of Alabama Oneonta Center for Tobacco Products Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Lecig Enterprises Inc Center for Tobacco Products Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Vapors Inc. d/b/a Vapors of Alabama Gardendale Center for Tobacco Products Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Twisted Vapors Center for Tobacco Products Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Vapors Inc d/b/a Vapors of Alabama of Jasper Center for Tobacco Products Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Vapors Inc. d/b/a Vapors of Alabama Arab Center for Tobacco Products Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
JP Ventures LLC dba iVape Center for Tobacco Products Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Glenn Burkett Naples Corporation Office of Human and Animal Food Operations East Division IV Unapproved New Drugs/Misbranded
ECI Pharmaceuticals, LLC Center for Drug Evaluation and Research | CDER Failure to Register and List
Indiana Chem-Port Center for Drug Evaluation and Research | CDER CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top